Intervention for Persons Leaving Residential Substance Abuse Treatment

Substance Use Disorders Clinical Trial

Official title:

Intervention for Persons With Co-Occurring Disorders Leaving Residential Tx

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02670902
• Other study ID #: K01DA035330
• Status: Completed
• Phase: N/A
• Start date: May 1, 2017
• Est. completion date: December 31, 2020

Study information

• Verified date: May 2022
• Source: New York University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment. The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.

Description:

This randomized pilot study will examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services. More specifically, 60 participants will be randomized to either CTI (n=30) or enhanced usual discharge planning services (n=30) at the time of discharge. Participants will complete a baseline interview (prior to randomization) and 3-, 6-, 9- and 12-month follow-up assessments post-discharge.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: December 31, 2020
• Est. primary completion date: May 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Eligible participants will be enrolled in residential substance abuse treatment and who are at least 18 years of age, speak English, and expect to be discharged within 3 months.

Exclusion Criteria:

• Individuals that do not meet the aforementioned inclusion criteria will be excluded

from the study.More specifically, the following categories will be excluded:

1. Anyone under the age of 18

2. Non-English speaking individuals due to limited resources

3. Individuals who are considered vulnerable/protected populations, including children, pregnant women, and prisoners.

4. Individuals judged by clinical treatment staff to be in immediate crisis, i.e., suicide watch or inadequate decisional capacity to participate in the study.

Related Conditions & MeSH terms

• Substance Use Disorders
• Substance-Related Disorders

Intervention

Behavioral:
• Critical Time Intervention-Residential (CTI-R)
CTI-R is a 9-month, time-limited intervention that aims to produce an enduring impact by effectively linking individuals to both professional services (substance abuse and health and mental health providers) and social supports (e.g., family and friends) and by providing emotional and practical support. Participants in the CTI-R condition will also receive usual discharge services from the residential substance abuse treatment program.
• Enhanced Usual Discharge Services-Residential
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.

Locations

Country	Name	City	State
United States	New York University	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
New York University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Enrollment	Proportion of participants enrolled in the study as measured by the research records	Baseline
Primary	Change in retention	Proportion of participants completed the study as measured by the research records	3, 6, 9, and 12 months
Primary	Short-term Relapse	Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index	3 months
Primary	Use of aftercare services	Proportion of participants who were linked to aftercare services (i.e. substance use treatment) at the time of discharge as measured by the Treatment Service Review (TSR)	3 months
Primary	Housing	Proportion of participants housed at the time of discharge	3 months
Secondary	Short-term Social Support	Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey	3 months
Secondary	Short-term Self-Efficacy	Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."	3 months
Secondary	Short-term Mental Health	Level of mental health severity as measured by the Brief Symptom Inventory	3 months
Secondary	Change in Relapse	Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index	3, 6, and 9 months
Secondary	Long-term Relapse	Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index	12 months
Secondary	Change in Social Support	Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey	3, 6, and 9 months
Secondary	Long-term Social Support	Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey	12 months
Secondary	Change in Self-Efficacy	Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."	3, 6, and 9 months
Secondary	Long-term Self-Efficacy	Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."	12 months
Secondary	Change in Mental Health	Level of mental health severity as measured by the Brief Symptom Inventory	3, 6, and 9 months
Secondary	Long-term Mental Health	Level of mental health severity as measured by the Brief Symptom Inventory	12 months